Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
KROS
Keros Therapeutics Reports Positive Phase 2 Data
| 2024-06-17 |
PHARMACEUTICAL